Trial Profile
A Proof of Concept Study to Investigate the Effect of IPT803 Adjunct Treatment in Patients With Parkinson's Disease
Status:
Completed
Phase of Trial:
Phase I/II
Latest Information Update: 17 Jun 2020
Price :
$35
*
At a glance
- Drugs IPT-803 (Primary)
- Indications Parkinson's disease
- Focus Proof of concept; Therapeutic Use
- Sponsors Tools4Patient
- 13 Jun 2020 Status changed from active, no longer recruiting to completed.
- 09 Mar 2020 Planned End Date changed from 1 Feb 2020 to 31 Mar 2020.
- 22 Nov 2019 Planned End Date changed from 1 Oct 2019 to 1 Feb 2020.